Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
22.09
+0.78 (3.66%)
Dec 20, 2024, 4:00 PM EST - Market closed
Teva Pharmaceutical Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$21.00
Upside
-4.93%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +26.75% | Dec 18, 2024 |
| Barclays | Barclays | Buy Maintains $22 → $25 | Buy | Maintains | $22 → $25 | +13.17% | Oct 23, 2024 |
| JP Morgan | JP Morgan | Hold Maintains $16 → $18 | Hold | Maintains | $16 → $18 | -18.52% | Oct 21, 2024 |
| UBS | UBS | Strong Buy Maintains $24 → $26 | Strong Buy | Maintains | $24 → $26 | +17.70% | Sep 3, 2024 |
| Barclays | Barclays | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | -0.41% | Aug 1, 2024 |
| UBS | UBS | Strong Buy Maintains $22 → $24 | Strong Buy | Maintains | $22 → $24 | +8.65% | Jul 10, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $19 → $23 | Strong Buy | Maintains | $19 → $23 | +4.12% | Jun 27, 2024 |
| Barclays | Barclays | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | -4.93% | Jun 5, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $18 → $21 | Strong Buy | Maintains | $18 → $21 | -4.93% | May 30, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $19 → $20 | Buy | Reiterates | $19 → $20 | -9.46% | May 13, 2024 |
| Barclays | Barclays | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | -9.46% | May 9, 2024 |
| JP Morgan | JP Morgan | Sell → Hold Upgrades $14 | Sell → Hold | Upgrades | $14 | -36.62% | Mar 8, 2024 |
| Piper Sandler | Piper Sandler | Hold → Buy Upgrades $12 → $19 | Hold → Buy | Upgrades | $12 → $19 | -13.99% | Feb 12, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $10 → $11 | Hold | Maintains | $10 → $11 | -50.20% | Feb 5, 2024 |
| Barclays | Barclays | Buy Maintains $15 → $17 | Buy | Maintains | $15 → $17 | -23.04% | Feb 5, 2024 |
| Barclays | Barclays | Buy Maintains $14 → $15 | Buy | Maintains | $14 → $15 | -32.10% | Jan 29, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.